The idea that these cases may represent some form of early-stage parkinsonism that will convert to DAT negative PD over time is not supported by long-term longitudinal studies.17,18 These individuals remain a hot topic of investigation, particularly within the ongoing longitudinal Parkinson’s progression marker initiative (PPMI). The gene discussed is SLC6A3; the disease is Parkinson disease.